IL310940A - Fucan and modified Fucan formulations for the treatment of conditions associated with capsular contracture and inhibition of fibrous growth around or on implants - Google Patents

Fucan and modified Fucan formulations for the treatment of conditions associated with capsular contracture and inhibition of fibrous growth around or on implants

Info

Publication number
IL310940A
IL310940A IL310940A IL31094024A IL310940A IL 310940 A IL310940 A IL 310940A IL 310940 A IL310940 A IL 310940A IL 31094024 A IL31094024 A IL 31094024A IL 310940 A IL310940 A IL 310940A
Authority
IL
Israel
Prior art keywords
implant
medically acceptable
treating
effective amount
therapeutically effective
Prior art date
Application number
IL310940A
Other languages
English (en)
Hebrew (he)
Original Assignee
Arc Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arc Medical Inc filed Critical Arc Medical Inc
Publication of IL310940A publication Critical patent/IL310940A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
IL310940A 2021-08-20 2022-08-18 Fucan and modified Fucan formulations for the treatment of conditions associated with capsular contracture and inhibition of fibrous growth around or on implants IL310940A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163235316P 2021-08-20 2021-08-20
US202263354322P 2022-06-22 2022-06-22
PCT/CA2022/051254 WO2023019360A1 (en) 2021-08-20 2022-08-18 Fucan and modified fucan compositions for the treatment of conditions related to capsular contracture and to inhibiting fibrous growth around or on transplants

Publications (1)

Publication Number Publication Date
IL310940A true IL310940A (en) 2024-04-01

Family

ID=85239322

Family Applications (1)

Application Number Title Priority Date Filing Date
IL310940A IL310940A (en) 2021-08-20 2022-08-18 Fucan and modified Fucan formulations for the treatment of conditions associated with capsular contracture and inhibition of fibrous growth around or on implants

Country Status (10)

Country Link
US (1) US20240350531A1 (https=)
EP (1) EP4387630A4 (https=)
JP (1) JP2024532867A (https=)
KR (1) KR20240087708A (https=)
AU (1) AU2022328865A1 (https=)
CA (1) CA3229366A1 (https=)
IL (1) IL310940A (https=)
MX (1) MX2024002190A (https=)
WO (1) WO2023019360A1 (https=)
ZA (1) ZA202401941B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102024104757B4 (de) * 2024-02-21 2026-03-26 Acandis Gmbh Medizinische Vorrichtung mit verbesserter antithrombotischer Wirkung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933290B2 (en) * 2007-06-26 2015-01-13 Sofradim Production Sas Mesh implant
WO2019210414A1 (en) * 2018-05-02 2019-11-07 Arc Medical Devices Inc. Fucan-based compounds and complexes
US11446326B2 (en) * 2018-07-27 2022-09-20 ARC Medical Devices Highly sulfated fucans for the treatment of fibrous adhesions

Also Published As

Publication number Publication date
MX2024002190A (es) 2024-06-24
WO2023019360A1 (en) 2023-02-23
US20240350531A1 (en) 2024-10-24
EP4387630A4 (en) 2025-07-30
ZA202401941B (en) 2025-06-25
JP2024532867A (ja) 2024-09-10
EP4387630A1 (en) 2024-06-26
KR20240087708A (ko) 2024-06-19
AU2022328865A1 (en) 2024-03-14
CA3229366A1 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
Bharadwaj An overview on biomaterials and its applications in medical science
Bansal et al. Applications of some biopolymeric materials as medical implants: An overview
Reddy et al. Introduction to biomaterials
IL310940A (en) Fucan and modified Fucan formulations for the treatment of conditions associated with capsular contracture and inhibition of fibrous growth around or on implants
Williams Implantable prostheses
JP2024532867A5 (https=)
Fuller et al. Materials for medicine
Sharma et al. Biomaterials and their applications
Suvaneeth et al. Biomaterials and biocompatibility
Williams The science and applications of biomaterials
Williams Biocompatibility: performance in the surgical reconstruction of man
Varghese et al. Biomaterials in medical applications
Yadav et al. Biomaterials in medical applications
Garg et al. Tribological performance of polymeric materials for biomedical applications
Bhat Overview of biomaterials
Dharadhar et al. Biomaterials and its medical applications
Kumar et al. An introduction to biomaterials
Woo et al. Biomaterials: Historical overview and current directions
Gayathry et al. Biomaterials for medical products
Haleem et al. Exploring biomaterials for healthcare: An extensive insight into capabilities and applications
Tripathi Green polymeric materials for medical implantable and non-implantable devices
Pandian et al. Exploring the Role of Biomaterials in Organ Implants
Kichura et al. BIOMATERIALS FOR MEDICAL PURPOSES PROGRESS PARALLEL WITH THE DEVELOPMENT OF CIVILIZATION
Sreeranjini BIOMATERIALS AND ITS APPLICATIONS IN REGENERATIVE MEDICINE
Singh et al. The Advent of Biopolymers for Potential Applications in the Medical and Pharmaceuticals Sector